Broadening off-label communications could erode FDA's approval standard as it would enable the uses of products never found to be safe or effective in patients and weaken consumer confidence in the FDA approval process.
Gene Green argues that off-label communications could undermine FDA standards and consumer trust.
Share
More from Gene Green
Maternal mortality in our country has more than doubled between 1987 and 2014, from 7.2 to 18 maternal deaths per 100,000 live births.
I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.
The Centers for Disease Control and Prevention reports that more than 700 women in the United States die each year due to complications related to pregnancy and childbirth.
If children that are impacted by traumatic stress receive early interventions and the trauma informed care they need, can the long-term health affects of trauma be mitigated in any way?
Other voices in this conversation
